A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo-Reference-Cited by-同舟云学术

A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo

Published:2001-06 Issue:3 Volume:11 Page:219-227
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:Melanoma Research

Author:

Carr A.,Mazorra Z.,Alonso D. F.,Mesa C.,Valiente O.,Gomez D. E.,Perez R.,Fernandez L. E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference24 articles.

1. Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

2. Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

3. Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans

4. Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale

5. Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ganglioside GM3-based anticancer vaccines: Reviewing the mechanism and current strategies;Biomedicine & Pharmacotherapy;2024-07

2. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma;Journal of Hematology & Oncology;2016-09-29

3. Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications;Clinical & Experimental Metastasis;2016-07-23

4. Gradual reduction of testosterone using a gonadotropin-releasing hormone vaccination delays castration resistance in a prostate cancer model;Oncology Letters;2016-06-07

5. A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies;Pediatric Blood & Cancer;2015-07-07